Tools for Germplasm Cryopreservation (SBIR [R43/R44])

The summary for the Tools for Germplasm Cryopreservation (SBIR [R43/R44]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Tools for Germplasm Cryopreservation (SBIR [R43/R44]): -Purpose: Tools for germplasm cryopreservation have become increasingly important in enabling repositories to meet the needs for establishing banks of animal germplasm for current and future research needs. This funding opportunity announcement (FOA) solicits applications from small business concerns (SBCs) for Small Business Innovation Research (SBIR) projects that propose innovative research in the areas of animal germplasm cryopreservation methods, reagents, equipment, biosecurity, and the detection of disease, including the vertical transmission of disease. (see more information listed in Section I. Funding Opportunity Description ). -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, RFA-RR-07-008, that solicits applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. -Funds Available and Anticipated Number of Awards For this funding opportunity, budgets and project periods pursuant to SBIR guidelines will be used. For Phase I ($100,000 total costs for 6 months) and Phase II SBIR ($750,000 total costs for two years). The participating organizations NCRR, NICHD and NIGMS intend to commit approximately $1.3M in FY 2008 to fund thirteen (13) Phase I, Phase II, or Fast Track applications under the SBIR set-aside funding mechanism. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.